Matthew Link
Chief Commercial Officer at Sight Sciences, Inc. (SGHT) since September 2023
Matthew Link has filed 14 insider reports with the SEC since September 2023, as director at FibroBiologics, Inc. (FBLG) and chief Commercial Officer at Sight Sciences, Inc. (SGHT). Matthew Link made no open-market purchases or sales in the last 12 months. The latest filing, on June 24, 2026, reports grant or award at FibroBiologics, Inc. (FBLG).
- Filings
- 14
- Companies
- 2
- Bought on market
- None
- Sold on market
- $521K
Companies where Matthew Link is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince January 2024 | $0.83 | Jun 24, 2026 | |||||
| Chief Commercial Officersince September 2023 | 832,293 | $521K | $10.62 | Nov 12, 2025 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 23, 2026FBLGSEC Form 4 filed by Director Link MatthewForm 4Grant or award
- Nov 12, 2025~$348KSGHTMatthew Link plans to sell 50,000 shares (~$348K)Form 144Planned sale
- Sep 3, 2025SGHTSEC Form 4 filed by Chief Commercial Officer Link MatthewForm 4
- Jul 2, 2025-$20KSGHTChief Commercial Officer Link Matthew sold $20,035 worth of shares (4,889 units at $4.10), decreasing direct ownership by 0.58% to 832,293 unitsForm 4Open-market sale
- Jun 12, 2025FBLGSEC Form 4 filed by Director Link MatthewForm 4Grant or award
- May 16, 2025SGHTChief Commercial Officer Link Matthew was granted 6,631 shares, increasing direct ownership by 0.80% to 837,182 unitsForm 4Grant or award
- Apr 2, 2025-$11.6KSGHTChief Commercial Officer Link Matthew sold $11,642 worth of shares (5,042 units at $2.31), decreasing direct ownership by 0.60% to 830,551 unitsForm 4Open-market sale
- Mar 11, 2025SGHTChief Commercial Officer Link Matthew was granted 172,043 shares, increasing direct ownership by 26% to 835,593 unitsForm 4Grant or award
- Oct 21, 2024-$245KSGHTChief Commercial Officer Link Matthew sold $244,901 worth of shares (42,318 units at $5.79), decreasing direct ownership by 6% to 663,550 unitsForm 4Open-market sale
- Oct 17, 2024-$245KSGHTChief Commercial Officer Link Matthew sold $244,878 worth of shares (41,704 units at $5.87), decreasing direct ownership by 6% to 705,868 unitsForm 4Open-market sale
- Aug 27, 2024FBLGSEC Form 4 filed by Director Link MatthewForm 4Grant or award
- Jan 24, 2024FBLGAmendment: SEC Form 3 filed by new insider Link MatthewForm 3/ANew insider
- Nov 14, 2023SGHTLink Matthew was granted 747,572 sharesForm 4Grant or award
- Sep 11, 2023SGHTMatthew Link became an insiderForm 3New insider
Compare Matthew Link with
- Matthew Link vs Brenton Taylor1 shared
- Matthew Link vs Hamid Khoja1 shared
- Matthew Link vs Kashif Rashid1 shared
- Matthew Link vs Jeremy B. Hayden1 shared
- Matthew Link vs James Rodberg1 shared
- Matthew Link vs David Badawi1 shared
Other insiders at the same companies
- Brenton TaylorSGHT
- Hamid KhojaFBLG
- Leigh SteinbergFBLG
- Kashif RashidSGHT
- Kathleen Hallisey RubinsFBLG
- Jeremy B. HaydenSGHT
- James RodbergSGHT
- David BadawiSGHT
- Alison BauerleinSGHT
- Paul BadawiSGHT
- Robert E. HoffmanFBLG
- Richard C. Cilento Jr.FBLG
- Niklas Victoria Ninon OliviaFBLG
- Tamara FountainSGHT
- Staffan EncrantzSGHT
- Gerhard F BurbachSGHT
Questions about Matthew Link
- What is Matthew Link's role at Sight Sciences, Inc.?
- Matthew Link reports to the SEC as chief Commercial Officer at Sight Sciences, Inc. (SGHT), according to the latest filing on November 12, 2025. Matthew Link has also filed as director at FibroBiologics, Inc. (FBLG).
- How many shares does Matthew Link own?
- After the latest filing that states it, Matthew Link directly owned 832,293 shares of Sight Sciences, Inc. (SGHT). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Matthew Link bought or sold stock recently?
- The most recent open-market sale was on July 2, 2025: sold 4,889 shares of Sight Sciences, Inc. (SGHT) for $20K at an average of $4.10.
- How do I get alerts when Matthew Link files?
- Follow Matthew Link on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Matthew Link (SEC CIK 0001565950). Totals count each trade once, skipping amendments whose original is on file, from Sep 12, 2023 on. View on SEC EDGAR · Get this as JSON